Australia Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking

Date: December 1, 2016
Pages: 50
Price:
US$ 1,000.00
Publisher: BAC Reports
Report type: Strategic Report
Delivery: E-mail Delivery - PDF (on default),
Hard Copy Mail Delivery (+US$ 190.00)
ID: A4045ECF969EN
Leaflet:

Download PDF Leaflet

Australia Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking
  • The report analyses Pharmaceuticals and Biotechnology Industry in Australia. It covers general statistics, including industry volumes by sales and income, and industry dynamics within the recent period. The description of industry structure by company is included as well, establishing extent of market concentration and evaluating companies’ market shares. Analysis includes detailed information about the internal and external factors that affect Pharmaceuticals and Biotechnology Industry in Australia.
  • The report provides detailed Pharmaceuticals and Biotechnology Industry comparative analysis with interrelated data on major companies. The areas under consideration are as follows:
    - company strategic position in the industry
    - profitability and margin analysis
    - assets turnover and credit ratios reviews
    - long-term solvency indicators
    - growth trends comparison
  • The report also presents company rankings by size, value, profit margin and growth history, thus giving a full picture of each company mentioned.
  • The report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases. Annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of the industry.

RESEARCH METHODOLOGY

DISCLAIMER

1. CORPORATE ANALYSIS OF AUSTRALIA PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY

1.1. Key Facts
1.2. Industry Volume
1.3. Industry Dynamics

2. AUSTRALIA PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY COMPARATIVE ANALYSIS

2.1. Stock Analysis
2.2. Current Market State
2.3. Comparative Financial Analysis
  2.3.1. Profitability Analysis
  2.3.2. Margin Analysis
  2.3.3. Assets Turnover Analysis
  2.3.4. Credit Ratios
  2.3.5. Long-Term Solvency Analysis
  2.3.6. Growth Over Prior Year Trends

3. AUSTRALIA PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY RANKINGS

3.1. Company Rankings by Size
3.2. Company Rankings by Value
3.3. Company Rankings by Profit Margins
3.4. Company Rankings by Growth History

4. AUSTRALIA PHARMACEUTICALS AND BIOTECHNOLOGY INDUSTRY NEWS

4.1. News & PR Activity Analysis
4.2. Australia Pharmaceuticals and Biotechnology Industry Significant Developments
4.3. Marketing News
4.4. Corporate Events

5. INDUSTRY EXPERTS FORECAST AND OPINIONS

APPENDIX: RATIO DEFINITIONS


LIST OF TABLES

Table 1. The list of Companies Included in the Research
Table 2. Australia Pharmaceuticals and Biotechnology Industry Snapshot
Table 3. Australia Pharmaceuticals and Biotechnology Industry Annual Revenues, Gross Profit and Net Income, 2011-2014
Table 4. Australia Pharmaceuticals and Biotechnology Industry Quarterly Revenues, Gross Profit and Net Income
Table 5. Australia Pharmaceuticals and Biotechnology Industry Annual Growth Rates, %
Table 6. Australia Pharmaceuticals and Biotechnology Industry Quarterly Growth Rates, %
Table 7. Australia Pharmaceuticals and Biotechnology Industry Companies Stock Performance
Table 8. Companies Market Shares in 2011-2014, %
Table 9. Australia Pharmaceuticals and Biotechnology Industry Companies Profitability Ratios
Table 10. Australia Pharmaceuticals and Biotechnology Industry Companies Margin Analysis Ratios
Table 11. Australia Pharmaceuticals and Biotechnology Industry Companies Assets Turnover Ratios
Table 12. Australia Pharmaceuticals and Biotechnology Industry Companies Credit Ratios
Table 13. Australia Pharmaceuticals and Biotechnology Industry Companies Long-Term Solvency Ratios
Table 14. Australia Pharmaceuticals and Biotechnology Industry Companies Growth Over Prior Year Ratios
Table 15. Australia Pharmaceuticals and Biotechnology Industry Leaders by Market Capitalization
Table 16. Australia Pharmaceuticals and Biotechnology Industry Leaders by Revenues
Table 17. Australia Pharmaceuticals and Biotechnology Industry Leaders by Net Income
Table 18. Australia Pharmaceuticals and Biotechnology Industry Leaders by Employees
Table 19. Australia Pharmaceuticals and Biotechnology Industry Leaders by Price per Earnings
Table 20. Australia Pharmaceuticals and Biotechnology Industry Leaders by Price to Sales
Table 21. Australia Pharmaceuticals and Biotechnology Industry Leaders by Price to Book
Table 22. Australia Pharmaceuticals and Biotechnology Industry Leaders by Price to Cash Flow
Table 23. Australia Pharmaceuticals and Biotechnology Industry Leaders by Profit Margin
Table 24. Australia Pharmaceuticals and Biotechnology Industry Leaders by Operating Margin
Table 25. Australia Pharmaceuticals and Biotechnology Industry Leaders by Return on Assets
Table 26. Australia Pharmaceuticals and Biotechnology Industry Leaders by Earnings per Share
Table 27. Australia Pharmaceuticals and Biotechnology Industry Leaders by Revenue Growth Rate


LIST OF FIGURES

Figure 1. Australia Pharmaceuticals and Biotechnology Industry Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Figure 2. Industry Concentration in 2014, %
Figure 3. Australia Pharmaceuticals and Biotechnology Industry Dynamics, 4 Year Trends
Figure 4. Australia Pharmaceuticals and Biotechnology Industry Dynamics, Last 4 Quarter Trends
Figure 5. Australia Pharmaceuticals and Biotechnology Industry 1-year Stock Chart
Figure 6. Australia Pharmaceuticals and Biotechnology Industry vs. Main Indexes 1-year Stock Chart
Figure 7. Australia Pharmaceuticals and Biotechnology Industry Structure by Companies, %
Figure 8. Growth-Share Matrix: Companies Strategic Position in Australia Pharmaceuticals and Biotechnology Industry (Recent Year Trends)
Figure 9. Growth-Share Matrix: Companies Strategic Position in Australia Pharmaceuticals and Biotechnology Industry (Recent Quarter Trends)
Figure 10. Return on Assets Chart by Companies in 2011-2014
Figure 11. Return on Equity Chart by Companies in 2011-2014
Figure 12. Profitability Peer Analysis
Figure 13. Profit Margin Chart by Companies in 2011-2014
Figure 14. Operating Margin Chart by Companies in 2011-2014
Figure 15. Margin Peer Analysis
Figure 16. Assets Turnover Peer Analysis
Figure 17. Current Ratio Chart by Companies in 2011-2014
Figure 18. Growth Over Prior Year Peer Analysis
Figure 19. Australia Pharmaceuticals and Biotechnology Industry Article Density Chart


THE FOLLOWING COMPANIES ARE INCLUDED IN THE RESEARCH:

Acuvax LimitedActinogen Limited.Acrux Ltd.
Agenix Ltd.Alchemia Ltd.Antisense Therapeutics Ltd.
Apollo Consolidated LimitedArturus Capital Limited.Avexa Ltd.
Benitec Ltd.BioDiem Ltd.Bionomics Ltd.
BioProspect Ltd.Biota Holdings Ltd.Biotron Ltd.
Bone Medical Ltd.BPH Corporate LimitedCalzada Limited
CBio LimitedCellestis Ltd.Cellmid Limited
Chemgenex Pharmaceuticals Ltd.Circadian Technologies Ltd.Clinuvel Pharmaceuticals Limited
Cryosite LimitedCSL Ltd.Eastland Medical Systems Limited
Fluorotechnics LimitedGenera Biosystems LimitedGenetic Technologies Ltd.
Giaconda LimitedGtech International Resources Ltd.HealthLinx Limited
Helicon Group LimitedHolista CollTech LimitedIDT Australia Limited
Immuron LimitedImugene Ltd.Living Cell Technologies Ltd.
Mayne Pharma Group LimitedMedical Developments International Ltd.Mesoblast Limited
Molecular Pharmacology (USA) Ltd.Neurodiscovery LimitedNovogen Limited
Nusep Holdings LtdOBJ Ltd.Patrys Limited
PharmaNet Group Ltd.Pharmaust Ltd.Pharmaxis Ltd.
Phosphagenics Ltd.Phylogica LimitedPrana Biotechnology Ltd.
Prima Biomed Ltd.Probiomics Ltd.Probiotec Limited
Progen Pharmaceuticals LimitedQRxPharma Pty Ltd.Select Vaccines Ltd.
SIRTeX Medical Ltd.Solagran Ltd.Starpharma Holdings Limited
Stirling Products Ltd.Telesso Technologies LimitedTissue Therapies Ltd.
Tyrian Diagnostics Ltd.Viralytics LimitedVirax Holdings Ltd.
Vita Life Sciences Ltd.Xceed Capital Ltd

The above Industry Comparative Analysis is a half-ready report.
It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 3-5 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. Business Analytic Center (BAC) has information for more than 40,000 different companies available but it is impossible to have all reports updated immediately. That is why it takes 3-5 days to update a report after an order is received.

Skip to top


Ask Your Question

Australia Pharmaceuticals and Biotechnology Industry Comparative Analysis and Companies Ranking
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: